@article{article, title  = {{Cabazitaxel for Hormone-Relapsed Metastatic Prostate Cancer Previously Treated With a Docetaxel-Containing Regimen: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Adis}},

 url = {{http://eprints.whiterose.ac.uk/108856/ http://www.readcube.com/articles/10.1007/s40273-016-0457-1?author_access_token=rbXYVuOBuR58SeGgHskhpve4RwlQNchNByi7wbcMAY6MEWC31o0d4h78u4fova25uJYul-_IVvaUf5Ko-2nnX0OFXNZYPoqEMa_zYnT2yqE2DtYjUUNVTAI-S }},

 year = {{2016}},

 month = {{10}},

 author = {{Kearns B and Pandor A and Stevenson M and Hamilton J and Chambers D and Clowes M and Graham J and Kumar MS}},

 doi = {{10.1007/s40273-016-0457-1}},

 volume = {{35}},

 journal = {{PharmacoEconomics}},

 issue = {{4}},

 pages = {{415-424}},

 note = {{Accessed on 2024/10/19}}}